Plasma neurofilament heavy chain is not a useful biomarker in Charcot-Marie-Tooth disease

Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes

(2015) Xiaona Qiao et al.   MEDICINE

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study

(2014) Ching-Hua Lu et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis

(2013) Lenka Fialová et al.   JOURNAL OF NEUROIMMUNOLOGY

Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis

(2013) Lenka Fialová et al.   JOURNAL OF NEUROIMMUNOLOGY

High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A

(2013) Richard A. Lewis   JAMA Neurology

Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice

(2012) Ágnes Patzkó et al.   BRAIN

Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1G93A Mice that Model ALS

(2012) Ching-Hua Lu et al.   PLoS One

Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1

(2011) Kevin Garofalo et al.   JOURNAL OF CLINICAL INVESTIGATION

Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease

(2011) Sinéad M. Murphy et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

(2011) Davide Pareyson et al.   LANCET NEUROLOGY

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

(2011) Constantin d'Ydewalle et al.   NATURE MEDICINE

Genetic and clinical aspects of Charcot-Marie-Tooth's disease

(2010) H. Skre   CLINICAL GENETICS

A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect

(2010) Ching-Hua Lu et al.   JOURNAL OF NEUROSCIENCE METHODS

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker

(2009) Kevin Boylan et al.   JOURNAL OF NEUROCHEMISTRY

Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial

(2009) Joshua Burns et al.   LANCET NEUROLOGY

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

(2009) Joëlle Micallef et al.   LANCET NEUROLOGY